These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 24793345)

  • 1. Can paraoxonase 1 polymorphisms (L55 M and Q192 R) protect children with type 1 diabetes against lipid abnormalities?
    Fekih O; Triki S; Hellara I; Neffati F; Rejeb J; Ommezzine A; Chouchane S; Guediche MN; Bouslama A; Najjar MF
    J Clin Lipidol; 2014; 8(3):249-55. PubMed ID: 24793345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis.
    Asefi M; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Nomani H; Ebrahimi A; Tavilani H; Pourmotabbed T
    Br J Dermatol; 2012 Dec; 167(6):1279-86. PubMed ID: 22835076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
    Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
    Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Paraoxonase 1 (PON1) activity and lipid parameters in Tunisian smokers].
    Haj Mouhamed D; Ezzaher A; Araoud M; Neffati F; Douki W; Najjar MF
    Ann Biol Clin (Paris); 2010; 68(2):143-7. PubMed ID: 20348046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraoxonase 1 polymorphisms (L55M and Q192R) as a genetic marker of diabetic nephropathy in youth with type 1 diabetes.
    Fekih O; Triki S; Rejeb J; Neffati F; Douki W; Ommezzine A; Chouchane S; Guediche MN; Bouslama A; Najjar MF
    Endokrynol Pol; 2017; 68(1):35-41. PubMed ID: 26884296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormalities in the relationship of paraoxonase 1 with HDL and apolipoprotein A1 and their possible connection to HDL dysfunctionality in type 2 diabetes.
    Viktorinova A; Jurkovicova I; Fabryova L; Kinova S; Koren M; Stecova A; Svitekova K
    Diabetes Res Clin Pract; 2018 Jun; 140():174-182. PubMed ID: 29626583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraoxonase 1 activity and lipid profile in schizophrenic patients.
    Mabrouk H; Mechria H; Mechri A; Azizi I; Neffati F; Douki W; Gaha L; Najjar MF
    Asian J Psychiatr; 2014 Jun; 9():36-40. PubMed ID: 24813034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PON1 M/L55 mutation protects high-risk patients against coronary artery disease.
    Oliveira SA; Mansur AP; Ribeiro CC; Ramires JA; Annichino-Bizzacchi JM
    Int J Cardiol; 2004 Mar; 94(1):73-7. PubMed ID: 14996478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotypes of Common Polymorphisms in the PON1 Gene Associated with Paraoxonase Activity as Cardiovascular Risk Factor.
    Moreno-Godínez ME; Galarce-Sosa C; Cahua-Pablo JÁ; Rojas-García AE; Huerta-Beristain G; Alarcón-Romero LDC; Cruz M; Valladares-Salgado A; Antonio-Véjar V; Ramírez-Vargas MA; Flores-Alfaro E
    Arch Med Res; 2018 Oct; 49(7):486-496. PubMed ID: 30853125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral leishmaniasis is associated with marked changes in serum lipid profile.
    Liberopoulos EN; Apostolou F; Gazi IF; Kostara C; Bairaktari ET; Tselepis AD; Elisaf M
    Eur J Clin Invest; 2014 Aug; 44(8):719-27. PubMed ID: 24920396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PON1 activity is inversely related to LDL apoB carbonyl content in patients with coronary artery disease.
    Sharma R; Singh B; Mahajan M
    Kaohsiung J Med Sci; 2007 May; 23(5):225-31. PubMed ID: 17525004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin.
    Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Liamis GL; Kakaidi B; Tselepis AD; Cariolou MA; Elisaf MS
    Arch Med Res; 2007 May; 38(4):403-10. PubMed ID: 17416287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of several single nucleotide polymorphisms and high body mass index on serum lipid traits.
    Yin RX; Wu DF; Miao L; Htet Aung LH; Cao XL; Yan TT; Long XJ; Liu WY; Zhang L; Li M
    Biofactors; 2013; 39(3):315-25. PubMed ID: 23355348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship Between Paraoxonase-1 and Butyrylcholinesterase Activities and Nutritional Status in Mexican Children.
    Ramírez-Jiménez R; Martínez-Salazar MF; Almenares-López D; Yáñez-Estrada L; Monroy-Noyola A
    Metab Syndr Relat Disord; 2018 Mar; 16(2):90-96. PubMed ID: 29393817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.
    Göçmen AY; Gümüşlü S; Semiz E
    Clin Cardiol; 2004 Jul; 27(7):426-30. PubMed ID: 15298047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraoxonase 1 polymorphisms in patients with primary glomerulonephritis: a single-center study in Turkey.
    Eren Z; Kantarci G; Biyikli N; Arikan H; Tuglular S; Ergen A; Isbir T; Akoglu E
    Iran J Kidney Dis; 2012 May; 6(3):181-5. PubMed ID: 22555481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four polymorphisms of cholesteryl ester transfer protein gene and coronary stenosis in a Tunisian population.
    Rejeb J; Omezzine A; Boumaiza I; Rebhi L; Rejeb NB; Nabli N; Abdelaziz AB; Boughzala E; Bouslama A
    J Cardiovasc Med (Hagerstown); 2012 Sep; 13(9):546-53. PubMed ID: 22854712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of lipid metabolism under different urinary protein excretion in children with primary nephrotic syndrome.
    Hu P; Lu L; Hu B; Du PF
    Scand J Clin Lab Invest; 2009; 69(6):680-6. PubMed ID: 19468931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidant effect of atorvastatin is independent of PON1 gene T(-107)C, Q192R and L55M polymorphisms in hypercholesterolaemic patients.
    Sardo MA; Campo S; Bonaiuto M; Bonaiuto A; Saitta C; Trimarchi G; Castaldo M; Bitto A; Cinquegrani M; Saitta A
    Curr Med Res Opin; 2005 May; 21(5):777-84. PubMed ID: 15969877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients.
    Tomás M; Sentí M; García-Faria F; Vila J; Torrents A; Covas M; Marrugat J
    Arterioscler Thromb Vasc Biol; 2000 Sep; 20(9):2113-9. PubMed ID: 10978257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.